RISK

Trading carries substantial risk of loss. Prop evaluation fees are typically non-refundable and the majority of traders do not pass first attempts. This comparison is for informational purposes only and does not constitute financial advice. Read full risk warning

HEAD-TO-HEAD COMPARISON · 2026

Matrix Executions vs Ment Funding

Side-by-side comparison of trust scores, profit splits, payout speed, and real trader reviews. Independent data — no sponsored rankings.

MTRX

Matrix Executions

EST. 2018

MNTF

Ment Funding

MATRIX EXECUTIONS

METRIC

MENT FUNDING

0/100TIE

TRUST SCORE

TIE0/100

0/5TIE

RATING

TIE0/5

—

PROFIT SPLIT

—

MAX FUNDING

—

MIN COST

—

PAYOUT DAYS

—

PASS RATE

—

0TIE

REVIEW COUNT

TIE0

MATRIX EXECUTIONS DETAILS

STEPS: -phase

MENT FUNDING DETAILS

STEPS: -phase

Matrix Executions PROS

+Founded in 2018, Matrix Executions has a longer operating history than most prop firms, suggesting stability.
+No additional data is available to identify further above-average metrics for Matrix Executions.
+No additional data is available to identify further above-average metrics for Matrix Executions.
+No additional data is available to identify further above-average metrics for Matrix Executions.

Matrix Executions CONS

−Almost no firm data is provided beyond founding year, making meaningful comparison to industry averages impossible.
−Without profit split, funding, or challenge cost data, traders cannot evaluate value against industry benchmarks.
−Lack of transparency on payout, drawdown, and trading rules limits trader decision-making confidence significantly.

Ment Funding PROS

+Listed on PropDNA, giving traders a reference point for discovery
+No restrictive data points provided that could indicate unfavorable terms
+Absence of negative metrics means no confirmed below-average figures
+Firm identity is established enough to be catalogued for comparison

Ment Funding CONS

−No data provided on profit split, max funding, or challenge cost
−No trading conditions such as drawdown, profit target, or payout terms are available
−Traders cannot make an informed decision without any comparable metrics

PROPDNA VERDICT